Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
NACRES:
NB.15
UNSPSC Code:
41122107
Material:
clear bottom, clear wells, flat wells, polystyrene , polystyrene plate, round wells
Size:
96 wells
Sterility:
sterile
Binding type:
Tissue Culture (TC)-treated surface
Feature:
lid, skirt, 1 x 8 Stripwell™, plate format: 96 well standard
size
96 wells
well diam.
6.4 mm
material
clear bottom, clear wells, flat wells, polystyrene , polystyrene plate, round wells
description
growth area .32 cm2
sterility
sterile
feature
lid, skirt, 1 x 8 Stripwell™, plate format: 96 well standard
packaging
case of 100, pack of 25, case of 50 (individually wrapped)
manufacturer/tradename
Corning 9102
well working volume
75-200 μL
binding type
Tissue Culture (TC)-treated surface
Looking for similar products? Visit Product Comparison Guide
Application
Corning® 96-well (1 x 8 Stripwell™) is suitable for cell based assays.
Features and Benefits
- 8 well strip plate, assembled 12 strips per plate
- Egg-crate style strip holder allows each individual well to be positioned back into the plate once strip is broken
- 1 x 8 strips are designed to fit only one way into the strip holder, to avoid the chance of misorientation
- Flat bottom microplate with total well volume of 360 μL and recommended working volumes of 75 to 200 μL
- Surface treated for optimal cell attachment and to improve the binding of difficult to attach cell lines
- Individually wrapped with nonreversible lids containing condensation rings to reduce contamination
- Microplates are sterilized and certified nonpyrogenic
- Individual alphanumeric codes enable easy well identification
Legal Information
Corning is a registered trademark of Corning, Inc.
Stripwell is a trademark of Corning, Inc.
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Tejashree Redij et al.
Journal of computer-aided molecular design, 33(11), 973-981 (2019-11-24)
The Glucagon-like peptide 1 receptor (GLP-1R) is a well-established target for the treatment of type 2 diabetes and GLP-1R agonist-based therapies represent an effective approach which results in several GLP-1 analog drugs. However, the development of nonpeptidic agonist drugs targeting
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service